Clinical trials: Rilpivirine
Viral Control, Quality of Life
The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine
"AIDS" was once regarded as the Black Death of the 20th century. However, with the advent of cocktail therapy, the survival rate of infected people has been greatly improved and the average life expectancy has been increased.
- Conditions
- Viral Control, Quality of Life, Cabotegravir, Rilpivirine
- Trial name
- NCT07131826
- Testing
- Observational study, non-interventional
- Where
- Taiwan
- Volunteers
- 200 people
- Sponsor
- National Taiwan University Clinical Trial Center
Anti-Retroviral Agents, Efavirenz
Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression
According to the Thai National Guidelines for Treatment of HIV/AIDS 2014, the recommended first line ART regimen was 2 NRTIs backbone, TDF and FTC; plus 1 NNRTI, EFV, with RPV as an alternative one.
- Conditions
- Anti-Retroviral Agents, Efavirenz, HIV-1-infection, Sustained Virologic Response
- Trial name
- STEREOS (NCT03251690)
- Testing
- Tenofovir/Emtricitabine/Rilpivirine, Tenofovir/Emtricitabine/Efavirenz
- Volunteers
- 246 people
- Sponsor
- Mahidol University
Efficacy of Rilpivirine-based Regimens as Switch Therapy
Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected Patients
Background: Nevirapine (NVP)-based antiretroviral therapy (ART) remains to be used in HIV-infected patients in resource limited countries despite its compliance and adverse effect concerns.
- Trial name
- NCT03664440
- Testing
- Nevirapine, Rilpivirine
- Where
- Thailand
- Volunteers
- 106 people, healthy volunteers welcome
- Sponsor
- Mahidol University